The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study

By Homburg R.   Ray A.   Bhide P.   Gudi A.   Shah A.   Timms P.   Grayson K.  

Human Reproduction, Vol. 28, Iss. 4, 2013-04 ,pp. : 1077-1083

Oxford University Press

Access to resources Recommend Favorite

Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism

By Eldar-Geva Talia  

Human Reproduction, Vol. 20, Iss. 7, 2005-07 ,pp. : 1814-1819

Oxford University Press

Access to resources Recommend Favorite

Effects of metformin on serum insulin and anti-mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome

By Nascimento Areana Diogo   Lara Lucia Alves Silva   Rosa-e-Silva Ana Carolina Japur de Sá   Ferriani Rui Alberto   Reis Rosana Maria  

Gynecological Endocrinology, Vol. 29, Iss. 3, 2013-03 ,pp. : 246-249

Informa Healthcare

Access to resources Recommend Favorite

The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome

By Yilmaz Nafiye   Uygur Dilek   Dogan Muammer   Ozgu Emre   Salman Burcin   Mollamahmutoglu Leyla  

Gynecological Endocrinology, Vol. 28, Iss. 3, 2012-03 ,pp. : 162-165

Informa Healthcare

Access to resources Recommend Favorite

Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome

By Magoffin DA  

Human Reproduction, Vol. 13, Iss. 10, 1998-10 ,pp. : 2693-2698

Oxford University Press

Access to resources Recommend Favorite